Medical Decision Support Systems and Therapeutics: The Role of Autopilots

Clinical Pharmacology and Therapeutics

Volumn 99, Issue 2, 2016, Pages 161-164

  Woosley, R L ^a,b   Whyte, J ^c   Mohamadi, A ^c   Romero, K ^d  

^a AZCERT Inc and NDA Partners LLC   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CRITICAL PATH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION SUPPORT SYSTEM; EVIDENCE BASED PRACTICE; HEALTH PROGRAM; HUMAN; MEDICAL ERROR; MEDICAL INFORMATION; PATIENT SAFETY; PERSONALIZED MEDICINE; PRESCRIPTION; PRIORITY JOURNAL; TORSADE DES POINTES; ADVERSE DRUG REACTION; AUTOMATION; CLINICAL DECISION MAKING; CLINICAL DECISION SUPPORT SYSTEM; DRUG THERAPY; EVIDENCE BASED MEDICINE; MEDICATION ERROR; PHYSICIAN ORDER ENTRY SYSTEM; PREVENTION AND CONTROL; STANDARDS; TRENDS;

AUTOMATION; CLINICAL DECISION-MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG PRESCRIPTIONS; DRUG THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION ERRORS; PATIENT SAFETY;

EID: 84957308932     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.259     Document Type: Article

References (10)

1. Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Aspen, P., Wolcott, J., Bootman, J. L. & Cronenwett, L. R., editors. 2006.
2. James, J. T. A new, evidence-based estimate of patient harms associated with hospital care. J. Patient Saf. 9, 122-128 (2013).
3. Payne, T. H. et al. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts. J. Am. Med. Inform. Assoc. ocv011 (2015).
4. Woosley, R. L. & Romero, K. Assessing cardiovascular drug safety for clinical decision-making. Nat. Rev. Cardiol. 10, 330-337 (2013).
5. Mosholder, A. D., Mathew, J., Alexander, J. J., Smith, H. & Nambiar, S. Cardiovascular risks with azithromycin and other antibacterial drugs. N. Engl. J. Med. 368, 1665-1668 (2013).
6. Drew, B. J. et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 121, 1047-1060 (2010).
7. Haugaa, K. H. et al. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin. Proc. 88, 315-325 (2013).
8. Sorita, A. et al. Impact of clinical decision support preventing the use of QTprolonging medications for patients at risk for torsade de pointes. J. Am. Med. Inform. Assoc. 22, e21-e27 (2015).
9. Tisdale, J. E. et al. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ. Cardiovasc. Qual. Outcomes 7, 381-390 (2014).
10. Jameson, J. L. & Longo, D. L. Precision medicine - personalized, problematic, and promising. N. Engl. J. Med. 372, 2229-2234 (2015).